Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Induced Sputum Collection in COPD Patients With and Without a Vibroacoustic Device

Induced sputum is a non-invasive method to collect samples from the airways. It involves inhaling a saline mist to loosen mucus, which is then coughed up. The samples are used to study markers of lung disease. In some people, this procedure yields only small amounts of sample. This study looks at whether adding a vibroacoustic device during sputum induction can increase the amount of sputum collected in patients with chronic obstructive pulmonary disease (COPD). The device applies gentle sound-based vibrations to the chest to help move mucus in the airways. Each participant undergoes two sputum collection procedures on separate days: one with and one without the device. The order is assigned at random. The main comparison is the amount of sputum obtained with versus without the device in the same person. The study also assesses how well the procedure is tolerated.

Participants needed: 20
Trial details
Age: 40-70Biological sex: AllType: InterventionalSponsor: Fraunhofer-Institute of Toxicology and Experimental MedicineUpdated: Aug 19, 2026Locations: 1
Eligibility criteria

Able and willing to give written informed consent. [+6]

Any clinically relevant disease or condition which, in the opinion of the invest... [+20]

Status: Recruiting

Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma

The goal of this exploratory method-development study is to to establish and evaluate novel non-invasive methods to monitor airway inflammation induced by allergen challenge (both by instillation during bronchoscopy and by inhalation) in patients with mild allergic asthma. The investigator wants to further profile and develop the allergen challenge model by investigating the utility of various non-invasive monitoring methods. The hypothesis of the project is that local inflammatory changes in the lung induced by allergen can be captured by gas-enhanced magnetic resonance imaging (MRI) and analysis of exhaled breath. The validation of cellular outcome measures and non-invasive inflammometry can be used in future clinical trials for proof of concept of novel anti-inflammatory medications. Participants will undergo * methacholine challenge * 2 inhaled allergen challenges * 2 MRI with hyperpolarized xenon and gadolinium based contrast agent * 2 bronchoscopies with bronchoalveolar lavage (BAL) * segmental allergen challenge during the first bronchoscopy * spirometry * skin prick test and skin prick dilution tests * measurement of particles in exhaled air * nasal filter * nasal lavage * sputum induction * peak flow meter tests * exhaled NO (nictric oxide) * blood sampling (in total approx. 190 ml)

Participants needed: 15
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Fraunhofer-Institute of Toxicology and Experimental MedicineUpdated: Jul 24, 2026Locations: 1
Eligibility criteria

Able and willing to give written informed consent. [+10]

Any clinically relevant abnormal findings in physical examination, clinical chem... [+17]